These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
227 related articles for article (PubMed ID: 8524985)
1. D4 dopamine receptor binding affinity does not distinguish between typical and atypical antipsychotic drugs. Roth BL; Tandra S; Burgess LH; Sibley DR; Meltzer HY Psychopharmacology (Berl); 1995 Aug; 120(3):365-8. PubMed ID: 8524985 [TBL] [Abstract][Full Text] [Related]
2. Binding of typical and atypical antipsychotic agents to 5-hydroxytryptamine-6 and 5-hydroxytryptamine-7 receptors. Roth BL; Craigo SC; Choudhary MS; Uluer A; Monsma FJ; Shen Y; Meltzer HY; Sibley DR J Pharmacol Exp Ther; 1994 Mar; 268(3):1403-10. PubMed ID: 7908055 [TBL] [Abstract][Full Text] [Related]
3. Inverse agonist activity of atypical antipsychotic drugs at human 5-hydroxytryptamine2C receptors. Herrick-Davis K; Grinde E; Teitler M J Pharmacol Exp Ther; 2000 Oct; 295(1):226-32. PubMed ID: 10991983 [TBL] [Abstract][Full Text] [Related]
4. Binding of typical and atypical antipsychotic agents to transiently expressed 5-HT1C receptors. Roth BL; Ciaranello RD; Meltzer HY J Pharmacol Exp Ther; 1992 Mar; 260(3):1361-5. PubMed ID: 1347569 [TBL] [Abstract][Full Text] [Related]
5. Risperidone compared with new and reference antipsychotic drugs: in vitro and in vivo receptor binding. Schotte A; Janssen PF; Gommeren W; Luyten WH; Van Gompel P; Lesage AS; De Loore K; Leysen JE Psychopharmacology (Berl); 1996 Mar; 124(1-2):57-73. PubMed ID: 8935801 [TBL] [Abstract][Full Text] [Related]
6. Atypical neuroleptics have low affinity for dopamine D2 receptors or are selective for D4 receptors. Seeman P; Corbett R; Van Tol HH Neuropsychopharmacology; 1997 Feb; 16(2):93-110; discussion 111-35. PubMed ID: 9015795 [TBL] [Abstract][Full Text] [Related]
7. [A study on the pharmacological properties of atypical antipsychotic drugs: in vivo dopamine and serotonin receptor occupancy by atypical antipsychotic drugs in the rat brain]. Matsubara R Hokkaido Igaku Zasshi; 1993 Jul; 68(4):570-82. PubMed ID: 7687976 [TBL] [Abstract][Full Text] [Related]
8. The ratios of serotonin2 and dopamine2 affinities differentiate atypical and typical antipsychotic drugs. Meltzer HY; Matsubara S; Lee JC Psychopharmacol Bull; 1989; 25(3):390-2. PubMed ID: 2576319 [TBL] [Abstract][Full Text] [Related]
9. Effect of typical and atypical antipsychotic drugs on 5-HT2 receptor density in rat cerebral cortex. Matsubara S; Meltzer HY Life Sci; 1989; 45(15):1397-406. PubMed ID: 2571912 [TBL] [Abstract][Full Text] [Related]
10. Inverse agonist actions of typical and atypical antipsychotic drugs at the human 5-hydroxytryptamine(2C) receptor. Rauser L; Savage JE; Meltzer HY; Roth BL J Pharmacol Exp Ther; 2001 Oct; 299(1):83-9. PubMed ID: 11561066 [TBL] [Abstract][Full Text] [Related]
11. The importance of serotonin-dopamine interactions in the action of clozapine. Meltzer HY Br J Psychiatry Suppl; 1992 May; (17):22-9. PubMed ID: 1358125 [TBL] [Abstract][Full Text] [Related]
12. [35S]Guanosine-5'-O-(3-thio)triphosphate binding as a measure of efficacy at human recombinant dopamine D4.4 receptors: actions of antiparkinsonian and antipsychotic agents. Newman-Tancredi A; Audinot V; Chaput C; Verrièle L; Millan MJ J Pharmacol Exp Ther; 1997 Jul; 282(1):181-91. PubMed ID: 9223553 [TBL] [Abstract][Full Text] [Related]
13. Atypical antipsychotics: mechanism of action. Seeman P Can J Psychiatry; 2002 Feb; 47(1):27-38. PubMed ID: 11873706 [TBL] [Abstract][Full Text] [Related]
14. Modulation of the clozapine structure increases its selectivity for the dopamine D4 receptor. Liégeois JF; Bruhwyler J; Damas J; Rogister F; Masereel B; Geczy J; Delarge J Eur J Pharmacol; 1995 Feb; 273(3):R1-3. PubMed ID: 7737323 [TBL] [Abstract][Full Text] [Related]
15. Long-term effects of S(+)N-n-propylnorapomorphine compared with typical and atypical antipsychotics: differential increases of cerebrocortical D2-like and striatolimbic D4-like dopamine receptors. Tarazi FI; Yeghiayan SK; Baldessarini RJ; Kula NS; Neumeyer JL Neuropsychopharmacology; 1997 Sep; 17(3):186-96. PubMed ID: 9272485 [TBL] [Abstract][Full Text] [Related]
16. A neurochemical basis for the antipsychotic activity of loxapine: interactions with dopamine D1, D2, D4 and serotonin 5-HT2 receptor subtypes. Singh AN; Barlas C; Singh S; Franks P; Mishra RK J Psychiatry Neurosci; 1996 Jan; 21(1):29-35. PubMed ID: 8580115 [TBL] [Abstract][Full Text] [Related]
17. Risperidone: a novel antipsychotic with balanced serotonin-dopamine antagonism, receptor occupancy profile, and pharmacologic activity. Leysen JE; Janssen PM; Megens AA; Schotte A J Clin Psychiatry; 1994 May; 55 Suppl():5-12. PubMed ID: 7520908 [TBL] [Abstract][Full Text] [Related]
18. Long-term effects of JL 13, a potential atypical antipsychotic, on rat dopamine and serotonin receptor subtypes. Moran-Gates T; Massari C; Graulich A; Liégeois JF; Tarazi FI J Neurosci Res; 2006 Aug; 84(3):675-82. PubMed ID: 16810690 [TBL] [Abstract][Full Text] [Related]
19. Dopamine and serotonin receptors: amino acid sequences, and clinical role in neuroleptic parkinsonism. Seeman P; Corbett R; Nam D; Van Tol HH Jpn J Pharmacol; 1996 Jul; 71(3):187-204. PubMed ID: 8854201 [TBL] [Abstract][Full Text] [Related]
20. Differential regulation of D2 and D4 dopamine receptor mRNAs in the primate cerebral cortex vs. neostriatum: effects of chronic treatment with typical and atypical antipsychotic drugs. Lidow MS; Goldman-Rakic PS J Pharmacol Exp Ther; 1997 Nov; 283(2):939-46. PubMed ID: 9353417 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]